References
- BlinmanPKingMNormanRVineyRStocklerMPatients’ preferences for cancer treatments: an overview of methods and applications in oncologyAnn Oncol20122351104111022234737
- The EuroQol GroupEuroQol – a new facility for the measurement of health related quality of lifeHealth Policy19901619920810109801
- BrazierJCzoski-MurrayCRobertsJBrownMSymondsTKelleherCEstimation of a preference-based index from a condition-specific measure: the King’s Health QuestionnaireMed Decis Making200828111312617641139
- BrazierJUsherwoodTHarperRThomasKDeriving a preference-based single index from the UK SF-36 Health SurveyJ Clin Epidemiol19985111111511289817129
- YoungTAYangYBrazierJETsuchiyaAThe use of Rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5DMed Decis Making201131119521020525959
- AaronsonNKAhmedzaiSBergmanBThe European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst19938553653768433390
- DrummondMFSculpherMJTorranceGWO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes3rd edOxfordOxford University Press2005
- McTaggart-CowanHTecklePPeacockSMapping utilities from cancer-specific health-related quality of life instruments: a review of the literatureExpert Rev Pharmacoecon Outcomes Res201313675376524219051
- RowenDBrazierJYoungTDeriving a preference-based measure for cancer using the EORTC-QLQC30Value Health201114572173121839411
- YoungTAYangYBrazierJETsuchiyaACoyneKThe first stage of developing preference-based measures: constructing a health-state classification using Rasch analysisQual Life Res200918225326519082759
- CellaDRosenbloomSKBeaumontJLDevelopment and validation of eleven symptom indexes to evaluate response to chemotherapy for advanced cancerJ Natl Compr Canc Netw201193132421233242
- CellaDPaulDYountSWhat are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN)Cancer Invest200321452653514533442
- BjordalKde GraeffAFayersPMA 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patientsEur J Cancer2000361796180710974628
- KaasaSBrenneELundJAProspective randomised multicenter trial on single fraction radiotherapy (8 Gy x1) versus multiple fractions (3 Gy x10) in the treatment of painful bone metastasesRadiother Oncol20062927828416793154
- GundyCMFayersPMGroenvoldMComparing higher order models for the EORTC QLQ-C30Qual Life Res20122191607161722187352
- TabachnickBGFidellLSUsing Multivariate Statistics5th edBostonAllyn and Bacon2007
- HornJLA rationale and test for the number of factors in factor analysisPsychometrika19653017918514306381
- OstlundUWennman-LarsenAGustavssonPWengstromYWhat symptom and functional dimensions can be predictors for global ratings of overall quality of life in lung cancer patients?Support Care Cancer2007151199120517431688
- TomaselloGde AzambujaEDinhPSnojNPiccart-GebhartMJumping higher: is it still possible? The ALTTO trial challengeExpert Rev Anticancer Ther20088121883189019046108
- Mplus User’s Guide [Computer Program]Los Angeles, CAMuthén and Muthén1998–2011
- WareJESnowKKKosinskiMGandekBSF-36® Health Survey Manual and Interpretation GuideBostonNew England Medical Center, The Health Institute1993
- McDonaldRPTest Theory: A Unified TreatmentNew JerseyLawrence Erlbaum1999
- RaschGProbabilistic Models for Some Intelligence and Attainment TestsChicagoUniversity of Chicago Press1960
- RUMM 2020 [Computer Program]PerthRUMM Laboratory2003
- PallantJFTennantAAn introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS)Br J Clin Psychol20074611817472198
- NormanRCroninPVineyRKingMStreetDRatcliffeJInternational comparisons in valuing EQ-5D health states: a review and analysisValue Health20091281194120019695009